跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞复美 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lenalidomide Capsules
Approved
化学药品
Lenalidomide Capsules
Celgene Europe BV
🇨🇳 National Medical Products Administration
Approval Date
May 9, 2019
Approval ID
7MazXbKTavc
Company
Celgene Europe BV
Type
化学药品
Approval Details
Approval Id
7MazXbKTavc
Approval Number
H20171345
Generic Name
来那度胺胶囊
Generic Name En
Lenalidomide Capsules
Trade Name
瑞复美
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
5mg
Reg Date
2019-05-09
Expired Date
2022-12-19
Company Name
Celgene Europe BV
Company Address
Winthontlaan 6 N, 3526KV Utrecht, The Netherlands
Production Company Name
Celgene International SARL
Production Company Address
Route de Perreux 1,2017 Boudry,Switzerland
Company Detail Path
/organization/celgene-europe-bv
Production Company Detail Path
/organization/celgene-international-sarl-belgium
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 9, 2019
Approval ID
7MazXbKTavc
Type
化学药品
Back to NMPA Approvals